Home   >  
Neuro Signaling Pathway

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
(+/-)-Narwedine Chemical Structure
BCP17760 (+/-)-Narwedine 1668-86-6
Narwedin is a competitive and reversible cholinesterase(AChE) inhibitor.
Huperzine A Chemical Structure
BCP31534 Huperzine A 120786-18-7
Huperzine A is isolated and purified from the herbs of Lycopodium serratum.
Cyclanoline Chemical Structure
BCP25162 Cyclanoline 18556-27-9
Cyclanoline is an acetylcholinesterase inhibitor isolated from Stephania venosa tuber.
Physostigmine salicylate Chemical Structure
BCP25378 Physostigmine salicylate 57-64-7
Physostigmine salicylate is a reversible cholinesterase inhibitor, a parasympathomimetic alkaloid.
Acotiamide Chemical Structure
BCP21087 Acotiamide 185106-16-5
Acotiamide, also known as YM-443 and Z-338, is a drug approved in Japan for the treatment of postprandial fullness, upper abdominal bloating, and early satiation due to functional dyspepsia. It acts as an acetylcholinesterase inhibitor.
Acotiamide hydrochloride trihydrate Chemical Structure
BCP09343 Acotiamide hydrochloride trihydrate 773092-05-0
Acotiamide, also known as YM-443 and Z-338,acts as an acetylcholinesterase inhibitor.
Neostigmine Methylsulfate Chemical Structure
BCP11922 Neostigmine Methylsulfate 51-60-5
Neostigmine methylsulfate is a reversible inhibitor of acetylcholinesterase, can not cross the blood-brain barrier.
Physostigmine Chemical Structure
BCP19735 Physostigmine 57-47-6
Physostigmine is an alkaloid and noted to act as a potent and reversible inhibitor of cholinesterase.
Demecarium bromide Chemical Structure
BCP24065 Demecarium bromide 56-94-0
Demecarium is a parasympathomimetic that acts as an acetylcholinesterase inhibitor.
Sophoflavescenol Chemical Structure
BCP24815 Sophoflavescenol 216450-65-6
Sophoflavescenol is a prenylated flavonol, which shows great inhibitory activity with IC50 of 0.013 μM against Phosphodiesterase 5 (PDE5), and also inhibits RLAR, HRAR, AGE, BACE1, AChE and BChE with IC50s of 0.30 µM, 0.17 µM, 17.89 µg/mL, 10.98 µM, 8.37 µM and 8.21 µM, respectively.
123下一页共 25 条记录 1 / 3 页